Corticosteroids and erythropoeitin-receptor agonists

CS McLachlan - CMAJ, 2008 - Can Med Assoc
The excellent meta-analysis by Ryan Zarychanski and associates demonstrated that the use
of erythropoietinreceptor agonists in critically ill patients does not improve clinically …

Erythropoietin-receptor agonists in critically ill patients: a meta-analysis of randomized controlled trials

R Zarychanski, AF Turgeon, L McIntyre, DA Fergusson - CMAJ, 2007 - Can Med Assoc
Introduction: Anemia and the need for red blood cell transfusions are common among
patients admitted to intensive care units. Erythropoietin has been used to decrease the need …

Treating critically ill anaemic patients with erythropoietin: why not?

S Lasocki, A Kimmoun, G Chanques, L Velly… - Intensive care …, 2020 - Springer
Dear Editor, We read with great interest the clinical practice guidelines on transfusion
strategies recently published in the journal [1]. Although it followed a well designed and …

Methylprednisolone neutralizes the beneficial effects of erythropoietin in experimental spinal cord injury

A Gorio, L Madaschi, B Di Stefano… - Proceedings of the …, 2005 - National Acad Sciences
Inflammation plays a major pathological role in spinal cord injury (SCI). Although
antiinflammatory treatment using the glucocorticoid methyprednisolone sodium succinate …

Erythropoietin strikes a new cord

SA Goldman, M Nedergaard - Nature Medicine, 2002 - nature.com
There are currently no effective means to treat acute spinal cord injury, except for
glucocorticoids, which produce moderate benefits at best. A new study suggests …

Treating critically ill anemic patients with erythropoietin: less is more

S Oczkowski, A Shah, C Aubron, M Wijnberge… - Intensive Care …, 2021 - Springer
We read with interest Lasocki et al.'s letter [1]. We agree with many points, especially their
call for further research into the clinical effects of erythropoietin (EPO) in critically ill patients …

[PDF][PDF] Erythropoietin use in the critically ill: current evidence

SJ Warrillow - Critical Care and Resuscitation, 2008 - researchgate.net
Critical Care and Resuscitation• Volume 10 Number 3• September 2008 258 have acute
renal failure (the low–normal range). Interestingly, these levels are not substantially different …

Single exposure to erythropoietin modulates Nerve Growth Factor expression in the spinal cord following traumatic injury: comparison with methylprednisolone

F Fumagalli, L Madaschi, P Brenna, L Caffino… - European journal of …, 2008 - Elsevier
Acute lesions of the spinal cord lead to dramatic changes in neuronal function. In the present
study, we examined the possible involvement of neurotrophic factors in the action of the drug …

A Multicenter assessment of the on-label and off-label usage of erythropoietic agents (epoetin alfa and darbepoetin alfa) in critically ill ICU patients: A retrospective …

SP Lee - 2006 - scholarscompass.vcu.edu
Objective To describe off-label utilization of erythropoietic agents in ICU patients. Methods A
retrospective, observational study design was used to describe off-label utilization of …

Safety and efficacy of erythropoiesis-stimulating agents in critically ill patients admitted to the intensive care unit: a systematic review and meta-analysis

E Litton, P Latham, J Inman, J Luo, P Allan - Intensive Care Medicine, 2019 - Springer
Purpose Severe immune dysregulation is common in patients admitted to the intensive care
unit (ICU) and is associated with adverse outcomes. Erythropoietin-stimulating agents …